Cardioprotective activity of fruit of Lagenaria siceraria (Molina) standley on doxorubicin induced cardiotoxicity in rats

International Journal of Pharmacology

Volumn 4, Issue 6, 2008, Pages 466-471

  Fard, M Hassanpour ^a   Bodhankar, S L ^b   Dikshit, Madhumira ^c  

^a BIRJAND UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b BHARATI VIDYAPEETH DEEMED UNIVERSITY   (India)

^c UNIVERSITY OF PUNE   (India)

Author keywords

Cardioprotective activity; Doxorubicin; Electrocardiogram; Lagenaria siceraria

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CREATINE KINASE MB; DOXORUBICIN; GLUTATHIONE; GUM ARABIC; LACTATE DEHYDROGENASE; LAGENARIA SICERARIA FRUIT; PLANT MEDICINAL PRODUCT; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CARDIOTOXICITY; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DRUG SAFETY; ELECTROCARDIOGRAM; HEART PROTECTION; HEART RATE; HISTOPATHOLOGY; LACTATE DEHYDROGENASE BLOOD LEVEL; LIPID PEROXIDATION; MALE; NONHUMAN; QT INTERVAL; RANDOMIZATION; RAT; ST SEGMENT; WISTAR RAT;

EID: 63749087788     PISSN: 18117775     EISSN: 18125700     Source Type: Journal    
DOI: 10.3923/ijp.2008.466.471     Document Type: Article

References (21)

1. Cirillo, R., G. Sacco, S. Venturella, J. Brightwell, A. Giachetti and S. Manzini, 2000. Comparison of doxorubicin-and MEN 10755-induced long-term progressive cardiotoxicity in the rat. J. Cardiovasc Pharm., 35: 100-108.
2. Deshpande, J.R., A.A. Choudhari, M.R. Mishra, V.S. Meghre, S.G. Wadodkar and A.K. Dorle, 2008. Beneficial effects of Lagenaria siceraria (Mol.) Standley fruit epicarp in animal models. Indian J. Exp. Biol., 46: 234-242.
3. Fadillioglu, E., E. Oztas, H. Erdogan, M. Yagmurca, S. Sogut, M. Ucar and M.K. Irmak, 2004. Protective effects of caffeic acid phenethyl ester on doxorubicin-induced cardiotoxicity in rats. J. Applied Toxicol., 24: 47-52.
4. Hardman, J.G. and L.E. Limbird, 2001. Goodman and Gilman's the Pharmacological Basis of Therapeutics. 10th Edn. McGraw-Hill, New York.
5. Hemnani, T. and M.S. Parihar, 1998. Reactive oxygen species and oxidative DNA damage. Indian J. Physiol. Pharmacol., 42: 440-452.
6. Karou, D., M.H. Dicko, J. Simpore and A.S. Traore, 2005. Antioxidant and antimicrobial activities of polyphenols from ethnomedicinal plants of Burkina Faso. Aft. J. Biotechnol., 4: 823-828.
7. Lowry, O.H., N.J. Rosenbrough, A.L. Farr and R.J. Randall, 1951. Protein measurement with the folin phenol reagent. J. Biol. Chem., 193: 265-275.
8. Maisuthisakul, P., M. Suttajit and R. Pongsawatmanit, 2007. Assessment of phenolic content and free radical scavenging capacity of some Thai indigenous plants. Food Chem., 100: 1409-1418.
9. Misra, H.P. and I. Fridovich, 1972. The role of superoxide anion in the auto-oxidation of epinephrine and a simple assay for superoxide dismutase. J. Biol. Chem., 247: 3170-3175.
10. Morishima, I., H. Matsui, H. Mukawa, K. Hayashi, Y.T. Toki, K. Okumura, T. Ito and T. Hayakawa, 1998. Melatonin, a pineal hormone with antioxidant property, protects against adriamycin cardiomyopathy in rats. Life Sci., 63: 511-521.
11. Moron M.S., J.W. Depierre and B. Mannervik, 1979. Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochem. Biophys. Acta, 582: 67-78.
12. Mostafa, A.M., M.N. Nagi, A.C. Al-Rikabi, O.A. Al-Shabanah and H.A. El-Kashef, 1999. Protective effect of aminoguanidine against cardiovascular toxicity of chronic doxorubicin treatment in rats. Res. Commun. Mol. Pathol. Pharmacol., 106: 193-202.
13. Mukherjee, S., S.K. Banerjee, M. Maulik, A.K. Dinda, K.K. Talwar and S.K. Maulik, 2003. Protection against acute adriamycin-induced cardiotoxicity by garlic: Role of endogenous antioxidants and inhibition of TNF-α expression. BMC Pharmacol., 3: 16-18.
14. Ogura, M., 2001. Adriamycin (Doxorubicin). Gan. Kagaku Ryoho, 28: 1331-1338.
15. Patil, L. and R. Balaraman, 2005. Protective effect of green tea extract on doxorubicin induced cardiotoxicity in rats. OPEM., 5: 137-143.
16. Saad, S.Y., T.A. Najjar and A.C. Al-Rikabi, 2001. The preventive role of deferoxamine against acute doxorubicin-induced cardiac, renal and hepatic toxicity in rats. Pharmacol. Res., 43: 211-218.
17. Sayed-Ahmed, M.M., M.M. Khattab, M.Z. Gad and A.M. Osman, 2001. Increased plasma endothelin-1 and cardiac nitric oxide during doxorubicin-induced cardiomyopathy. Pharmacol. Toxicol., 89: 140-144.
18. Seifert, C.F., M.E. Nesser and D.F. Thompson, 1994. Dexrazoxane in the prevention of doxorubicin-induced cardiotoxicity. Ann. Pharmacother., 28: 1063-1072.
19. Serrano, J., C.M. Palmeira, D.W. Kuehl and K.B. Wallace, 1999. Cardioselective and cumulative oxidation of mitochondrial DNA following subchronic doxorubicin administration. Biochem. Biophys. Acta., 1411: 201-205.
20. Slater, T.F. and B.C. Sawyer, 1971. The stimulatory effects of carbon tetrachloride and other halogenoalkanes or peroxidative reactions in rat liver fractions in vitro. Biochem. J., 123: 805-814.
21. Vergely, C., S. Delemasure, Y. Cottin and L. Rochette, 2007. Preventing the cardiotoxic effects of anthracyclines: From basic concepts to clinical data. Heart Metab., 35: 1-7.